No darkhorsestock Idea this week.
With the market down about 10% from its peak and the smallcap index down almost 20%, it’s understandable that some investors are feeling nervous. However, it’s important to remember that occasional dips are a normal part of the market cycle and don’t necessarily reflect any issues with the underlying companies or fundamentals. Infact majority of individual stocks are down somewhere around 35%+.
While many individual stocks are down significantly, it’s crucial to maintain a long-term perspective and avoid making hasty decisions based on short-term fluctuations. Selling your stocks in a panic could result in significant losses, particularly if you’re not able to hold onto them for at least a few years.
For those who are new to investing, it’s important to recognise that the stock market is not a get-rich-quick scheme. Patience and a long-term view are essential for success, particularly during periods of volatility like the current one. So, hang in there and don’t let short-term market fluctuations throw you off course!
Venus Remedies
Venus Remedies has experienced a sharp 60% drop in its stock price, despite being debt-free and having positive cash flow. While sales and profitability have declined somewhat, there is no obvious explanation for the steep drop.
However, upon closer examination, it appears that Venus Remedies is simply one of many pharma companies that have suffered in the current market climate. While the percentage drop may vary, most pharma companies have been significantly impacted.
So, while the drop in Venus Remedies’ stock price is certainly concerning, it’s worth noting that the company is not alone in facing these challenges.
We expect the market to pick up from Q2FY24 onwards.
Portfolio Management Service
We’ve received many user requests for our PMS service, but we’re still far from launching it. Our team is currently analyzing portfolios of various PMS providers, and most of them are not even able to beat index returns. We don’t want to be just another PMS provider, so we’re testing various portfolio models before launching our own.
Last year, we set up a portfolio in April that delivered impressive returns, even during the market correction. At its peak, the portfolio was up by 20-25% in just a few months.
Currently, we’re working on a new model portfolio for a company that has asked us to deploy 10 crores. We plan to share this portfolio from the beginning, so others can track and invest alongside us. Stay tuned for updates!
